Gossamer Bio, Inc.

$GOSS, a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension, is the leader of the Prism MarketView Public Health index so far today.

Share This Article

 

About the Author

Gossamer Bio, Inc.

Joey Ramson